N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine

C103H95ClN24O3 — CID 159554482

IUPACN-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine
SMILESCOc1ccc(C2(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)cc1.Nc1nccn2c(C3CCC(CNC(=O)c4c[nH]c5ccccc45)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC(=O)c4ccc5ccccc5n4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4c(Cl)cccc4[nH]3)c12
InChIInChI=1S/C31H29N7O.C30H29N7O.C24H21N5O.C18H16ClN5/c32-29-28-27(26-17-22-6-2-4-8-24(22)36-26)37-30(38(28)16-15-33-29)21-11-9-19(10-12-21)18-34-31(39)25-14-13-20-5-1-3-7-23(20)35-25;31-28-27-26(25-15-20-5-1-3-7-23(20)35-25)36-29(37(27)14-13-32-28)19-11-9-18(10-12-19)16-34-30(38)22-17-33-24-8-4-2-6-21(22)24;1-30-17-8-6-16(7-9-17)24(10-11-24)23-28-20(21-22(25)26-12-13-29(21)23)19-14-15-4-2-3-5-18(15)27-19;19-12-5-2-6-13-11(12)9-14(22-13)15-16-17(20)21-7-8-24(16)18(23-15)10-3-1-4-10/h1-8,13-17,19,21,36H,9-12,18H2,(H2,32,33)(H,34,39);1-8,13-15,17-19,33,35H,9-12,16H2,(H2,31,32)(H,34,38);2-9,12-14,27H,10-11H2,1H3,(H2,25,26);2,5-10,22H,1,3-4H2,(H2,20,21)
InChIKeyMFUUXXXXOZVKDN-UHFFFAOYSA-N
MW1752.51 g/mol
LogP20.29
Rot. Bonds16

About N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine

N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine (PubChem CID 159554482) has the molecular formula C103H95ClN24O3 and a molecular weight of 1752.51 g/mol. Its IUPAC name is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine.

Molecular Properties

Compound NameN-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine
PubChem CID159554482
Molecular FormulaC103H95ClN24O3
Molecular Weight1752.51 g/mol
Exact Mass1750.77
IUPAC NameN-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine
SMILESCOc1ccc(C2(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)cc1.Nc1nccn2c(C3CCC(CNC(=O)c4c[nH]c5ccccc45)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC(=O)c4ccc5ccccc5n4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4c(Cl)cccc4[nH]3)c12
InChIInChI=1S/C31H29N7O.C30H29N7O.C24H21N5O.C18H16ClN5/c32-29-28-27(26-17-22-6-2-4-8-24(22)36-26)37-30(38(28)16-15-33-29)21-11-9-19(10-12-21)18-34-31(39)25-14-13-20-5-1-3-7-23(20)35-25;31-28-27-26(25-15-20-5-1-3-7-23(20)35-25)36-29(37(27)14-13-32-28)19-11-9-18(10-12-19)16-34-30(38)22-17-33-24-8-4-2-6-21(22)24;1-30-17-8-6-16(7-9-17)24(10-11-24)23-28-20(21-22(25)26-12-13-29(21)23)19-14-15-4-2-3-5-18(15)27-19;19-12-5-2-6-13-11(12)9-14(22-13)15-16-17(20)21-7-8-24(16)18(23-15)10-3-1-4-10/h1-8,13-17,19,21,36H,9-12,18H2,(H2,32,33)(H,34,39);1-8,13-15,17-19,33,35H,9-12,16H2,(H2,31,32)(H,34,38);2-9,12-14,27H,10-11H2,1H3,(H2,25,26);2,5-10,22H,1,3-4H2,(H2,20,21)
InChIKeyMFUUXXXXOZVKDN-UHFFFAOYSA-N
XLogP20.29
TPSA384.11 Ų
H-Bond Donors11
H-Bond Acceptors20
Rotatable Bonds16
Heavy Atoms131
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001752.51
LogP ≤ 520.29
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1020

Analyze N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine?
The IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine (CID 159554482) is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine.
What is the SMILES notation for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine?
The canonical SMILES for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine is COc1ccc(C2(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)cc1.Nc1nccn2c(C3CCC(CNC(=O)c4c[nH]c5ccccc45)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC(=O)c4ccc5ccccc5n4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4c(Cl)cccc4[nH]3)c12.
What is the InChIKey of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine?
The InChIKey is MFUUXXXXOZVKDN-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H29N7O.C30H29N7O.C24H21N5O.C18H16ClN5/c32-29-28-27(26-17-22-6-2-4-8-24(22)36-26)37-30(38(28)16-15-33-29)21-11-9-19(10-12-21)18-34-31(39)25-14-13-20-5-1-3-7-23(20)35-25;31-28-27-26(25-15-20-5-1-3-7-23(20)35-25)36-29(37(27)14-13-32-28)19-11-9-18(10-12-19)16-34-30(38)22-17-33-24-8-4-2-6-21(22)24;1-30-17-8-6-16(7-9-17)24(10-11-24)23-28-20(21-22(25)26-12-13-29(21)23)19-14-15-4-2-3-5-18(15)27-19;19-12-5-2-6-13-11(12)9-14(22-13)15-16-17(20)21-7-8-24(16)18(23-15)10-3-1-4-10/h1-8,13-17,19,21,36H,9-12,18H2,(H2,32,33)(H,34,39);1-8,13-15,17-19,33,35H,9-12,16H2,(H2,31,32)(H,34,38);2-9,12-14,27H,10-11H2,1H3,(H2,25,26);2,5-10,22H,1,3-4H2,(H2,20,21).
What are the key properties of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine?
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine has a molecular weight of 1752.51 g/mol, XLogP of 20.29, 16 rotatable bonds, 11 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-1H-indole-3-carboxamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]quinoline-2-carboxamide;1-(4-chloro-1H-indol-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1H-indol-2-yl)-3-[1-(4-methoxyphenyl)cyclopropyl]imidazo[1,5-a]pyrazin-8-amine is sourced from PubChem (CID 159554482), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).